Evercore Partners has announced that Anthony Fry will join the firm’s Advisory business as a Senior Managing Director, based in Evercore’s London office, on 1 January 2008.
Evercore Partners has announced that Anthony Fry will join the firm’s Advisory business as a Senior Managing Director, based in Evercore’s London office, on 1 January 2008.
Fry joins from Lehman Brothers, where he was Head of UK Investment Banking and Chairman of the Media Group and subsequently Senior Advisor. During his three years at Lehman Brothers, he established Lehman as a significant force in both investment banking, leading the successful defenses of The London Stock Exchange, and corporate broking, notably on behalf of Lloyds TSB.
Fry is the third Senior Managing Director to join Evercore’s European business this year, following the appointments of Ian Ferguson from Merrill Lynch and Edward Banks from JPMorgan Cazenove in September.
Evercore Partners is an investment banking boutique and investment firm. Evercore’s Advisory business counsels its clients on mergers, acquisitions, divestitures, restructurings and other strategic transactions. Evercore’s Investment Management business manages private equity funds and traditional asset management services for sophisticated institutional investors. Evercore serves a diverse set of clients around the world from its offices in New York, Los Angeles, San Francisco, London, Mexico City and Monterrey, Mexico.
Evercore Europe, based in London, was established in 2006 following Evercore’s acquisition of Braveheart Financial Services Limited, and has 22 employees including Chief Executive, Bernard Taylor, and Senior Managing Directors, Julian Oakley, Lord
Michael Forsyth, Philippe Camus, Edward Banks and Ian Ferguson, in addition to Anthony Fry when he joins in January.
Evercore has advised on some of the largest and most complex European M&A transactions over the past two years, including VNU’s USD 11.6 billion sale to a private equity consortium, Credit Suisse’s USD 9.9 billion sale of its Winterthur insurance unit to AXA, UCB’s euro 4.4 billion acquisition of Schwarz Pharma, Smiths Group Plc’s USD 5.1 billion sale of its Aerospace division to GE and Gedeon Richter of Hungary’s proposed USD 1.3 billion acquisition of Polpharma in Poland.
